<DOC>
	<DOCNO>NCT02923076</DOCNO>
	<brief_summary>Allogeneic hematopoietic cell transplantation CCR5 Δ32/Δ32 unrelated donor , perform first time `` Berlin patient '' , provide evidence date long-term control HIV infection . Stringent criterion select human leukocyte antigen ( HLA ) -matched conventional donor low prevalence CCR5 Δ32/Δ32 homozygous genotype ( &lt; 1 % ) make pursuit `` patient number 2 '' unsuccessful many year . Cord blood ( CB ) transplantation allow permissive HLA-matching criterion , make search HLA-compatible Δ32/Δ32 CB unit potentially feasible transplantation HIV-infected individual . The investigator team involve trial recently report first case CCR5 delta32/delta32 CB transplantation patient HIV infection , show reduction patient 's latent viral reservoir , upon achievement full CB chimerism , resistance CD4 T-lymphocytes infection HIV . This proof concept lead Spanish National Transplant Organization ( ONT ) generate inventory 150 CCR5 Δ32/Δ32 CB unit readily available transplant . From initial evidence repository CB unit , financial support Fundación Mutua Madrileña ( FMM ) allow investigator launch first pilot clinical trial indication . The study launch January 2016 Hospital Universitario Puerta de Hierro Majadahonda . All HIV virology reservoir analysis carry AIDS Immunopathology Unit Spanish Instituto de Salud Carlos III . Three additional transplant centre Spain also shortly open trial .</brief_summary>
	<brief_title>HIV Eradication Through Cord-blood Transplantation</brief_title>
	<detailed_description />
	<criteria>Inform consent , previously approve board , require order carry procedure relate study . HIV infection . Hematologic malignancies condition standard indication allogeneic hematopoietic cell transplantation . See indication European Society Blood Marrow Transplantation ( EBMT ) . [ Sureda A. et al . Indications allo autoSCT haematological disease , solid tumour immune disorder : current practice Europe , 2015 . Bone Marrow Transplantation ( 2015 ) 50 , 10371056 . ] Lack HLAidentical relate donor Availability least one cord blood unit CCR5 delta32 homozygous meet quality standard . Availability HLAidentical relate donor Contraindication allogeneic stem cell transplantation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Allogeneic Hematopoietic Cell Transplantation</keyword>
</DOC>